← FDA DRUG APPROVALS

FDA ANDA · ANDA074351

ETOPOSIDE

Sponsor: HOSPIRA

APPLICATION
ANDA074351
TYPE
ANDA
ORIGINAL APPROVAL
1995-08-30
LATEST ACTION
2002-04-10
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ETOPOSIDEDiscontinued
ETOPOSIDE 20MG/ML · INJECTABLE · INJECTION

Approval history

2002-04-10Manufacturing (CMC) · Supplement 2AP
2002-03-12Manufacturing (CMC) · Supplement 3AP
1999-07-28Manufacturing (CMC) · Supplement 1AP
1995-08-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →